Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for Amneal Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleChintu Patel
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Chintu Patel: trading record in brief
Chintu Patel, listed as chief executive, appears in our data through filings on Amneal Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 15 December 2021 to 10 August 2026, the count stands at 5 filings.
No open-market sale appears; the market trades are 1 purchase worth €367k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 2 option exercises.
The record was last updated on 12 August 2026 with a share grant in Amneal Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,766 days ago, on 17 December 2021. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chintu Patel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,381,734 sharesClass A Common StockSEC:0001628280-26-056297:0
59,931 sharesClass A Common StockSEC:0001628280-26-015285:0
579,710 sharesClass A Common StockSEC:0001628280-25-010688:0
24,753,252 sharesClass A Common StockSEC:0001209191-23-054738:0
100,000 shares@ US$4.13100.0% of flowClass A Common StockSEC:0001209191-21-070258:0
Canonical exit: 15 Mar 2022 (T+90)
5 of 5 declarations
